<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="42003">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02088424</url>
  </required_header>
  <id_info>
    <org_study_id>mohd-1978</org_study_id>
    <nct_id>NCT02088424</nct_id>
  </id_info>
  <brief_title>the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION</brief_title>
  <official_title>Insulin Resistance and Recurrent Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      THE  INSULIN RESISTANCE IN RECURRENT ABORTION
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      THE ROLE OF INSULIN RESISTANCE IN RECURRENT ABORTION
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>fasting blood glucose</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Click here for more information about this study: the role of insulin resistance in recurrent abortion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fasting Insulin</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>oral glucose tolerance test</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Recurrent Abortion</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <description>cases with recurrent abortion with insulin resisance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP B</arm_group_label>
    <description>cases that are pregnant with no history of recurrent abortion with no insulin resistance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>insulin resistance(fasting glucose/fasting insulin)</intervention_name>
    <description>insulin resistance(fasting glucose/fasting insulin )</description>
    <arm_group_label>group A</arm_group_label>
    <arm_group_label>GROUP B</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Women  in the child bearing period between 23-40 years.

          2. All patients are pregnant.

          3. The gestational age of both groups 6-13 weeks
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women  in the child bearing period between 23-40 years.

          2. All patients are pregnant.

          3. The gestational age of both groups 6-13 weeks

        Exclusion Criteria:

          1. Patients with gestational diabetes and gestational impaired glucose tolerance.

          2. The patients who took medication that could affect glucose metabolism at the time of
             the study

          3. Patients with other causes of recurrent abortion as(thyroid dysfunction, uterine
             anomalies chromosomal abnormalities, antiphspholipid antibody syndrome, uterine
             anomalies and TORCH syndrome).

          4. Patients with PCOS.

          5. Obese patients(BMI&gt;30)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>23 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>mohamed a selem, master</last_name>
    <phone>00201116724786</phone>
    <email>drghost_3000@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ain shams maternity hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ABDELLATIF G ELKHOLY, M D</last_name>
    </contact>
    <investigator>
      <last_name>ABDELLATIF G ELKHOLY, M D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://www.recurrentabortion.org/</url>
    <description>THE ROLE OF INSULIN RESISTANCE IN RECURRENT ABORTION</description>
  </link>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>March 8, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>mohamed ahmed selem</investigator_full_name>
    <investigator_title>THE ROLE OF INSULIN RESISTANCE IN RECURRENT MISCARRIAGE</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Abortion, Habitual</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
